Drug
IDH305
IDH305 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_1
2
50%
Ph phase_2
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 3 finished
Non-Completion Rate
100.0%
3 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(3)
Detailed Status
Withdrawn3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
active_not_recruiting125%
withdrawn375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_1
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
NCT02381886
withdrawnphase_1
A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
NCT02826642
withdrawnphase_2
Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
NCT02977689
withdrawnphase_2
Phase 2 Study of IDH305 in Low Grade Gliomas
NCT02987010
Clinical Trials (4)
Showing 4 of 4 trials
NCT02381886Phase 1
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
NCT02826642Phase 1
A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
NCT02977689Phase 2
Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
NCT02987010Phase 2
Phase 2 Study of IDH305 in Low Grade Gliomas
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4